ProductLife Group (PLG, Paris, France) has announced the acquisition of ELC Group, a Czech Republic-based regulatory consulting firm with 150 employees.
The strategic merger with ELC comes two months after the acquisition of US-based regulatory drug development consultancy DSI and helps to further accelerate the execution of PLG’s strategic plan, BoOst 2023, which aims to make PLG the worldwide leader in regulatory affairs and compliance. The new group will now include more than 600 staff members located in 40 countries.
“This is a landmark acquisition for PLG that complements our domain expertise and brings enhanced capabilities to our solutions, enabling us to provide sustainable business value to our clients. Adding offshore delivery capability in such a key location as India expands our ability to meet this goal,” commented Xavier Duburcq, PLG CEO.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.